Wolverine Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-39,899
| Closed | -$4.62M | – | 1845 |
|
|
2023
Q3 | $4.62M | Buy |
39,899
+7,314
| +22% | +$846K | 0.05% | 173 |
|
|
2023
Q2 | $3.35M | Sell |
32,585
-1,830
| -5% | -$188K | 0.04% | 215 |
|
|
2023
Q1 | $3.76M | Buy |
34,415
+14,982
| +77% | +$1.64M | 0.04% | 229 |
|
|
2022
Q4 | $2.21M | Buy |
+19,433
| New | +$2.21M | 0.02% | 346 |
|
|
2021
Q2 | – | Sell |
-1,443
| Closed | -$132K | – | 2461 |
|
|
2021
Q1 | $132K | Sell |
1,443
-13,777
| -91% | -$1.26M | ﹤0.01% | 1151 |
|
|
2020
Q4 | $1.11M | Buy |
15,220
+7,843
| +106% | +$574K | 0.01% | 447 |
|
|
2020
Q3 | $573K | Buy |
+7,377
| New | +$573K | 0.01% | 509 |
|
|
2020
Q2 | – | Sell |
-1,058
| Closed | -$31K | – | 1708 |
|
|
2020
Q1 | $31K | Sell |
1,058
-1,442
| -58% | -$42.3K | ﹤0.01% | 984 |
|
|
2019
Q4 | $90K | Hold |
2,500
| – | – | ﹤0.01% | 850 |
|
|
2019
Q3 | $68K | Buy |
2,500
+1,500
| +150% | +$40.8K | ﹤0.01% | 886 |
|
|
2019
Q2 | $24K | Hold |
1,000
| – | – | ﹤0.01% | 905 |
|
|
2019
Q1 | $26K | Buy |
+1,000
| New | +$26K | ﹤0.01% | 865 |
|
|
2017
Q3 | – | Sell |
-3,000
| Closed | -$35K | – | 1148 |
|
|
2017
Q2 | $35K | Hold |
3,000
| – | – | ﹤0.01% | 717 |
|
|
2017
Q1 | $44K | Buy |
3,000
+1,600
| +114% | +$23.5K | ﹤0.01% | 639 |
|
|
2016
Q4 | $22K | Buy |
+1,400
| New | +$22K | ﹤0.01% | 596 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 1558 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 1461 |
|